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Background: Early identification of autism spectrum disorder, intellectual developmental 
disorder, attention-deficit/hyperactivity disorder, and other neurodevelopmental disorders/
problems is crucial, yet diagnosis is often delayed for years under the often misguided 
“wait-and-see” paradigm. The early symptomatic syndromes eliciting neurodevelopmental 
clinical examinations-questionnaire (ESSENCE-Q) is a brief (12-item) screening question-
naire developed specifically for the purpose of speeding up the identification process of a 
wide variety of neurodevelopmental problems. The aims were to 1) estimate the reliability 
of the ESSENCE-Q, 2) evaluate the clinical cutoff levels suggested by the author of the 
ESSENCE-Q, and 3) propose optimal cutoff levels based on receiver operating character-
istic analysis.
Methods: The ESSENCE-Q was used for 1 year by a psychiatrist in Kochi, Japan, assessing 
children under the age of 6 years referred for developmental problems. The children were also 
clinically assessed with regard to whether or not they met criteria for a developmental disorder 
(diagnosis positive and diagnosis negative groups). We contrasted the results of the ESSENCE-Q 
and those of clinical diagnostic assessments in 130 cases.
Results: Cronbach’s alpha was 0.82, sensitivity was 0.94 (95% confidence interval [CI]: 
[0.88, 0.98]), and specificity 0.53 (95% CI: [0.28, 0.77]), which are reasonable psychometrics 
for a first-step screening tool. Based on receiver operating characteristic analysis, we recom-
mended an optimal cutoff level of yes $2 or maybe/a little $3 on the ESSENCE-Q (0.87 
(95% CI: [0.79, 0.92]) sensitivity and 0.77 (95% CI: [0.50, 0.93]) specificity).
Conclusion and implication: The ESSENCE-Q can be a good instrument for use as a 
screening tool for aiding in the process of early identification of neurodevelopmental disorders 
in clinical settings. To establish the broader validity and reliability of the ESSENCE-Q, case–
control studies and general population studies of children in different age groups are needed.
Keywords: ESSENCE, ESSENCE-Q, cutoff levels, receiver operating characteristic analysis
Introduction
ESSENCE is an acronym for early symptomatic syndromes eliciting neurodevelopmental 
clinical examinations. The concept was launched by Gillberg in 2010.1 ESSENCE is not a 
diagnostic term, but a concept that covers different kinds of early onset of developmental 
problems and disorders in children. Some of the most common disorders subsumed 
under ESSENCE are autism spectrum disorder (ASD), attention-deficit/hyperactivity 
disorder (ADHD), oppositional defiant disorder (ODD), tic disorder, developmental 
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coordination disorder (DCD), speech and language disorder 
(SLD), and intellectual disability/intellectual developmental 
disorder (IDD). ESSENCE also covers difficulties/problems 
not meeting criteria for a certain disorder, including border-
line intellectual functioning and other nonspecific learning 
difficulties. The concept further implies the almost universal 
coexistence of such disorders and problems, and that these 
coexistences are the rule rather than the exception.2 This 
clinical reality was already mentioned in the 1970s and early 
1980s, in papers discussing results suggesting that deficits in 
attention, motor control and perception, currently equivalent 
to ADHD with DCD, were generally associated with social, 
language, and behavioral impairments; that is, consistent 
with ASD as conceptualized today.3,4
The realization that neurodevelopmental disorders share 
symptoms across disorders has come to be largely ignored 
because of a preference for categorical “diagnostic boxes” 
with mutually exclusive diagnostic criteria. ESSENCE 
was launched with a view to alert clinicians and research-
ers to the complexity and overlap of neurodevelopmental 
problems with early onset, that is, before age 3 (−5) years. 
If a child before this age has one or more (usually several) 
major problems, lasting more than several months, in the 
following 12 fields: general development, communication/
language, social interrelatedness, perception, motor coor-
dination, attention/“listening”, activity, “behavior”, mood, 
feeding, sleep, and/or episodes/absences in the first years 
of childhood, this should be seen as a red flag for possible 
ASD, ADHD, ODD, DCD, tic disorder, SLD, and/or IDD. 
If unrecognized and not intervened, ESSENCE may predis-
pose to chronic or life-long neurodevelopmental disorders, 
other mental and psychiatric problems, drug abuse, physical 
disorders, antisocial behaviors, and premature death. With 
regard to prevalence, ESSENCE can be estimated to affect at 
least 10% of children under the age of 18 years. About half 
of the whole group is currently probably discovered already 
by age 6 years. It can also be expected that half or more of 
all “chronic” adult psychiatric patients suffer from disorders 
that are linked to ESSENCE.
ESSENCE is “the essence in child psychiatry and child 
public health”.5 In clinical practice today, there is a trend to 
ascertain “precise diagnosis” – such as ASD or ADHD – and 
that this should be followed by “specific interventions” target-
ing “the” diagnosis. Early detection of the child’s problems 
and starting intervention is important, because it helps to 
improve the abilities of the child and the quality of family life. 
On the other hand, the current trend of “very early diagnosis 
and very early intervention” often focuses on one diagnosis 
such as “ASD only” or “ADHD only” and tends to continue 
underestimating or ignoring the complexity of the real-life 
situation.6 If a child suffers from ASD, it is very likely that 
he/she may also suffer from ADHD7 and/or learning dis-
abilities including IDD8,9 or SLD.10 If a child has ADHD, it is 
also likely that he/she may suffer from other developmental 
disorders, such as obsessive compulsive disorder, DCD, and 
ODD.11 All this means that children with ESSENCE need to 
get a holistic approach. In the public health system, children 
with developmental problems need to be identified as early 
as possible even in cases where we might not immediately 
be able to pinpoint “a precise diagnosis”.12
The above-mentioned clinical aspects of ESSENCE also 
apply to Japan.
For early detection of developmental delay or problems, 
using validated screening tools is indispensible.13,14 To cap-
ture problems within the ESSENCE group, the ESSENCE-
Questionnaire (ESSENCE-Q) was developed in 2012.15 
ESSENCE-Q is a brief, simple “quick and easy” questionnaire 
consisting of 12 items covering the 12 areas referred to above. 
Responses of Yes (Y), Maybe/A Little (M/AL), or No (N) 
should be checked for each item. It is currently believed that 
all children scoring one or more Y or three or more M/AL 
should be regarded as being at risk for neurodevelopmental 
disorders and should be assessed by a developmental specialist 
or screened for possible further problems by a health visitor/
nurse.15 However there is no published study of the psychomet-
rics of the ESSENCE-Q yet. We translated this questionnaire 
into Japanese with the aim to use it as a parent questionnaire 
for a pilot study of the psychometrics of the ESSENCE-Q.
The aims of the study were to 1) estimate the reliabil-
ity (internal consistency) of the ESSENCE-Q, 2) evaluate 
the clinical cutoff level suggested by the author of the 
ESSENCE-Q (Y $1 or M/AL $3) as a parent questionnaire 
in a clinical setting, and 3) propose an optimal cutoff level 
based on receiver operating characteristic (ROC) analysis.
Method
This is a clinic-based investigation using the Japanese version 
of the ESSENCE-Q.
esseNce-Q
The ESSENCE-Q (Figure S1) is intended for use both in 
clinical practice and population research to help clinicians 
and researchers identify children with neurodevelopmental 
disorders. It is proposed to be useful as a brief interview 
by a specialist or as a questionnaire to be completed by 
parents and/or caregivers. It is not a diagnostic instrument 
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but a primary screening tool.15 It is freely available at www.
gnc.gu.se. For this study, we used the first version of the 
ESSENCE-Q, consisting of eleven items.
The translation procedure
Even though the words used in the ESSENCE-Q are simple, 
the cultural difference between European countries and Japan 
required a very careful translation process, that is, the Brislin’s 
translation model.16 After getting the author’s permission, a 
child psychiatrist in Japan (psychiatrist A, see below = first 
author of this paper), who has been working in the field 
of neurodevelopmental disorders for more than 25 years 
and understands the concept of ESSENCE, translated the 
ESSENCE-Q into Japanese. A native English speaker, who 
has been living in Japan for the previous 14 years and has been 
working as a lecturer of Japanese literature in a university for 
5 years and with enough knowledge of the Japanese language, 
conducted the back-translation into English. The author 
reviewed and compared the back-translation to the original 
instruments. After repeating this process, we established the 
Japanese version of the ESSENCE-Q.
setting
The research period was 1 year (from May 21, 2012 to 
May 8, 2013). The place was a developmental clinic in the 
Kochi Prefectural Medical Welfare Centre. The center is 
located in Kochi City, the capital of Kochi Prefecture on 
the island of Shikoku in southern Japan (population of about 
760,000, about 5,300 new births per year). The center has 
been in existence for about 20 years (the predecessor was 
the prefectural institution of orthopedically impaired children 
established in 1956), and a network and referral system have 
been built up over time so that the vast majority of young 
children with suspected developmental problems in the 
prefecture are referred to the center. Most cases are referred 
by pediatricians, child psychiatrists, speech therapists, 
preschool teachers, or public health nurses, but some come 
directly because of parental concerns regarding the child’s 
development. School children had also been referred to the 
center during the research period and a few adults had been 
assessed and diagnosed with a neurodevelopmental disorder, 
such as ASD and/or ADHD. During the research period, the 
number of new patients assessed at the center was 721. Of 
these, 539 were under the age of 6 years (75%).
Two psychiatrists (A and B), one pediatric neurologist and 
one orthopedist were responsible for the neurodevelopmental/
neuropsychiatric/medical assessments at the center. 
Psychiatrist A mainly assessed the preschool children and 
psychiatrist B (Figure 1) mainly the school children referred 
for different types of neurodevelopmental/neuropsychiatric 
problems. The pediatrician mainly saw the youngest children 
(mostly under the age of 3 years) referred because of neurode-
velopmental concerns. The referral reason for all children 
assessed by the orthopedist was concern regarding major 
motor developmental problems, especially cerebral palsy.
subjects
The ESSENCE-Q (Figure S1) was used by the research 
psychiatrist (psychiatrist A, see above) at the center. Of the 
182 patients seen by him during the research period, 145 
were under the age of 6 years. A nurse forgot to provide the 
ESSENCE-Q in five children. Ten children stopped coming to 
the center before a final decision with regard to diagnosis had 
been made. The remaining 130 children (mean age 3.5 years, 
boys:girls =5.2:1), assessed with the ESSENCE-Q and given 
a full clinical evaluation, and with a final decision regarding 
diagnosis/no diagnosis, were the study subjects (Figure 1).
clinical esseNce examination procedure
The ESSENCE-Q was completed by a parent (or a caretaker) 
of the referred child before the first clinical examination. 
The independent clinical assessment aimed at examining all 
kinds of developmental areas and disorders included under 
the ESSENCE umbrella (overall development, motor and 
perceptual performance, social communication and related 
behaviors, social interest, joint attention, imitation, play, 
reciprocal affective behavior, and insistence on sameness/
stereotypes).17–19 The following diagnostic categories were 
covered in the assessment; ASD, ADHD, IDD, DCD, SLD, 
ODD, borderline intellectual functioning, and learning dif-
ficulties. It also included unstructured clinical observations 
at the clinic and unstructured reports/interviews from parents 
and preschool teachers, combined with interviews using the 
attention deficit hyperactivity disorder Rating Scale-IV.20 
Cognitive assessments were performed mainly by using the 
Kyoto Scale of Psychological Development 2001,21 which 
has excellent psychometric properties, and with results that 
are closely correlated with those obtained at testing of young 
children with the Bayley Scales of Infant Development.22 
The Tanaka–Binet Scale of Intelligence23 was also used in 
several cases. The Tanaka–Binet test is a modified version 
for Japanese of the original Binet–Simon test, being a method 
by which mental age is evaluated and intelligence quotient is 
calculated from the ratio of mental age to chronological age. 
A cognitive assessment was performed in all cases of children 
displaying symptoms or who otherwise raised suspicion of 
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general cognitive delay. For a diagnosis of IDD, both the 
developmental/intellectual quotient and adaptive behavior 
levels were taken into account.24 For a diagnosis of DCD, 
occupational therapists together with the psychiatrist exam-
ined children while standing, walking, throwing and catch-
ing a ball, and performing other fine motor skills.25–29 The 
evaluations were repeatedly done over at least two different 
sessions separated by a minimum of a few weeks.30 The Inter-
national Statistical Classification of Diseases-10/Diagnostic 
and Statistical Manual of Mental Disorders-IV criteria for 
diagnoses of child psychiatric/neurodevelopmental disorders 
were used throughout.
Children who had been diagnosed with at least one 
ESSENCE diagnosis were classified as diagnosis positive, 
and children with no such diagnosis/diagnoses after clinical 
assessment were classified as diagnosis negative.
analysis
To estimate the reliability of the ESSENCE-Q, we used 
Cronbach’s alpha for internal consistency.
ROC curves were established for all possible sum scores 
of Y (1–11) and M/AL (1–11) separately. Youden index was 
also calculated. Youden index is ([sensitivity + specificity] −1) 
and ranges from 0 to 1.31
All analyses and drawings of ROC curves were performed 
using the R software (R version 3.2.2; The R Foundation 
for Statistical Computing, Vienna, Austria), and sensitivi-
ties, specificities, Youden indices, and their respective 95% 
confidence intervals (CIs) were calculated using the package 
epiR (The R Foundation for Statistical Computing).
ethics
The study was approved by the Ethics Review Board of Kochi 
Prefectural Medical Welfare Center. Verbal informed consent 
was obtained from all parents of the participating children.
Results
A total of 130 children, 109 boys (84%) and 21 girls (16%), 
were evaluated using the ESSENCE-Q and a full clinical 
assessment. The informants included 124 mothers (95%), five 
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Figure 1 The flowchart shows all new patients under the age of 6 years referred to the Neurodevelopmental Center during the research period.
Note: The children assessed with the ESSENCE-Q are in the bold rectangle at the bottom of the chart.
Abbreviation: esseNce-Q, esseNce-Questionnaire.
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fathers (4%), and one other caregiver (1%). The age at first 
visit varied from 21 to 72 months (mean age 41.6, standard 
deviation [SD] 13.7). Of the 130 children, 113 (96 boys 
and 17 girls) (87%) were given ESSENCE diagnoses, and 
17 (13 boys and four girls) (13%) were not.
In the diagnosis positive group, the age at the first visit 
varied from 22 to 72 months (mean 41.7, SD 13.7). In the 
diagnosis negative group, the first visit had occurred between 
21 and 64 months (mean 40.5, SD 13.5). Table 1 shows the 
diagnoses and other demographic information.
The Cronbach’s alpha across all eleven items was 
α=0.815.
Table 2 shows sensitivities and specificities of all possible 
cutoff levels. At the clinical cutoff levels by the author, the 
sensitivity was 0.94 (95% CI: [0.88, 0.98]), and the specificity 
was 0.53 (95% CI: [0.28, 0.77]).
Table 3 shows cutoff levels, sensitivities, and specificities 
with the three highest Youden indices.
Discussion
The reliability (internal consistency) of the ESSENCE-Q 
was found to be acceptable as good. The sensitivity and the 
specificity of the ESSENCE-Q using the suggested clinical 
cutoff level were 0.94 and 0.53, respectively.
The ESSENCE-Q is not a tool for diagnosis but a tool for 
primary screening of ESSENCE. In screening, it is important 
not to miss children being at risk for neurodevelopmental 
disorders who should be assessed by a developmental spe-
cialist or screened for possible further problems by a health 
visitor/nurse.15 Therefore, the emphasis of the ESSENCE-Q 
is on the sensitivity and not on the specificity. It is generally 
agreed that the ideal developmental screening test should 
err in the direction of false positive.32 Therefore, the cutoff 
scores suggested by the author are reasonable, even though 
specificity is only moderate.
On the other hand, a screening tool with high false posi-
tive rate will be costly.33 For a developmental screening test, 
it has been suggested that the best sensitivity and specificity 
balance is one where both are around 0.70–0.80.13,14 High 
sensitivity is crucial not to miss the children with devel-
opmental problems, whereas, to minimize over referrals, 
specificity should be closer to 80%.13 From the results in 
Table 2, the cutoff levels that have higher sensitivity than 
specificity and that have both sensitivity and specificity in 
0.70–0.80 were Y $2 or M/AL $3, and Y $3 or M/AL $3. 
Among cutoff levels that had relatively high Youden indi-
ces on the basis of the ROC analysis (Table 3), we would 
recommend Y $2 or M/AL $3 as the optimal cutoff level 
in a clinical neurodevelopmental center. When we used 
Y $2 or M/AL $3 as a cutoff level, the sensitivity was 0.87 
(95% CI: [0.79, 0.92]), and the specificity was 0.77 (95% 
CI: [0.50, 0.93]).
In this study, we explored cutoff levels of the ESSENCE-Q 
to improve the usability. We cannot decide one fixed cutoff 
level only from this pilot study, but if we could find a proper 
cutoff level (cutoff levels depend on the usage), it seems 
likely that the ESSENCE-Q can be a good instrument for use 
by nurses or general practitioners at child health care centers 
as a screening tool of neurodevelopmental disorders. It can 
also be administered by pediatricians or child psychiatrists as 
a parent screening questionnaire in clinical settings to cover 
important developmental areas.
Table 1 Diagnosis and other information of the 130 children
Diagnosis Boys Girls Total Mean age (months) (SD) at first 
visit and ESSENCE-Q screening 
Mean age (months) 
(SD) at diagnosis
Mean period between first visit 
and diagnosis (months) (SD)
asD 32 10 42 37.6 (12.7) 41.5 (13.4) 3.9 (6.9)
aDhD 14 0 14 49.1 (15.5) 60.7 (13.5) 11.6 (13.0)
iDD 11 1 12 43.9 (13.3) 46.6 (16.6) 2.7 (8.6)
BiF 1 1 2 46.5 46.5 0
lD 2 1 3 49.7 (11.4) 62.3 (11.4) 12.7 (11.4)
asD + iDD 17 3 20 35.4 (12.5) 36.4 (12.5) 1.0 (2.5)
asD + aDhD 8 1 9 48.6 (9.6) 57.3 (9.3) 8.8 (9.7)
asD + DcD 3 0 3 61.3 (5.9) 64.3 (3.2) 3.0 (3.0)
aDhD + iDD 4 0 4 42.5 (13.5) 49.8 (13.0) 7.3 (10.4)
aDhD + DcD 1 0 1 46 70 24
lD + DcD 1 0 1 47 67 20
asD + aDhD + DcD 2 0 2 44 69 25
Diagnosis (+) 96 17 113 41.7 (13.7) 47.3 (16.0) 5.5 (9.1)
Diagnosis (−) 13 4 17 40.5 (13.5) 54.8 (12.1) 13.5 (12.0)
all 109 21 130 41.6 (13.7) 48.1 (157) 6.6 (9.8)
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; BIF, borderline intellectual functioning; DCD, developmental coordination 
disorder; ESSENCE-Q, ESSENCE-Questionnaire; IDD, intellectual development disorder; LD, learning difficulties; SD, standard deviation.
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Screening tools should be simple, easy to be done, 
acceptable, and cheap,33 also inexpensive in terms of training 
and brief in its administration.32 ESSENCE-Q is fitting all these 
conditions. In the ESSENCE-Q, the questions are about “con-
cern” for each of the ESSENCE domains, not about specific 
symptoms or behaviors. “Yes”, “No”, and “Maybe/A Little” 
are the response alternatives. It may appear to be somewhat 
unspecified and vague, but this is actually the unique strength 
of the ESSENCE-Q. Behaviors of young children are very 
varied, and if we focus on a specific behavior too much, we 
tend to miss the behaviors that do raise some concern but that 
we have difficulty pinpointing exactly. Using the ESSENCE-Q 
provides an opportunity to catch nonspecified but critical 
information of the child’s development. ESSENCE-Q is not 
geared toward a specific neurodevelopmental diagnosis, and 
this could be the strength for screening across a whole range 
of ESSENCE problems. Thus, the ESSENCE-Q was devel-
oped to be used as a broad neurodevelopmental screening 
instrument in young children and differs from many other 
assessment tools targeting for example speech and language 
problems.34 The questionnaire could also be useful in a 
public health situation as a parent questionnaire and/or as an 
interview questionnaire and/or as an observation record. The 
cutoff scores might have to change according to the usage, 
and further studies are needed for this.
Two major limitations of the present study are that 1) the 
analyses were based on a clinical sample, and accordingly we 
do not yet know how well (or not well) the instrument works 
in a general population sample of children and 2) that the num-
ber of cases in the diagnosis negative group was very small. 
To establish the validity and the reliability of ESSENCE-Q, 
case–control studies in large numbers and population studies 
are needed. Additionally, we are planning other studies of the 
ESSENCE-Q, including some propositions for a decision-
making classification on preclinical and clinical stages.T
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Table 3 Combinations of cutoff levels with the three highest 
Youden indices
Cutoff levels Sensitivity 
95% CI
Specificity 
95% CI
Youden index 
95% CI
Y $2 or M/AL $5 0.76 0.88 0.64
(0.67, 0.84) (0.64, 0.99) (0.31, 0.82)
Y $2 or M/AL $3 0.87 0.77 0.63
(0.79, 0.92) (0.50, 0.93) (0.29, 0.86)
Y $2 or M/AL $4 0.79 0.82 0.61
(0.70, 0.86) (0.57, 0.96) (0.27, 0.82)
Notes: Youden index = sensitivity + specificity − 1. Bold combination best fit with 
rule of thumb sensitivity . specificity, sensitivity and specificity both in 0.70–0.80 
ranges, and Youden index high.
Abbreviations: CI, confidence interval; M/AL, Maybe/A Little; Y, Yes.
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Supplementary material
Please take a few minutes to read and check the following items.
• Y = Yes
• M/AL = Maybe/A Little
• N = No
Have you (or anybody else, who?_____) been concerned for more than a few months regarding a child’s
 1. General development
 2. Motor development/milestones
 3. Sensory reaction (eg, touch, sound, light, smell, taste, heat, cold, pain)
 4. Communication/language/babble
 5. Activity (overactivity/passivity) or impulsivity
 6. Attention/concentration/“listening”
 7. Social interaction/interest in other children
 8. Behavior (eg, repetitive, routine insistence)
 9. Mood (depressed, elated/manic, extreme irritability, crying spells)
 10. Sleep
 11. Feeding
Figure S1 esseNce-Q.
Abbreviation: esseNce-Q, esseNce-Questionnaire.
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